Oruka Therapeutics, Inc. (ORKA) Operating cash flow 2015–2025
Oruka Therapeutics, Inc. (ORKA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$88.2MFY2025 · since FY2015: -$10.5M → -$88.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.2M | — |
| FY2023 | -$5.0M | +54.1% |
| FY2022 | -$10.9M | +41.8% |
| FY2021 | -$18.8M | -142.9% |
| FY2020 | -$7.7M | -60.9% |
| FY2019 | -$4.8M | +41.8% |
| FY2018 | -$8.2M | +52.8% |
| FY2017 | -$17.5M | -16.6% |
| FY2016 | -$15.0M | -42.3% |
| FY2015 | -$10.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice